https://www.selleckchem.com/pr....oducts/imidazole-ket
ytes, and were later recruited to flowering mechanism in angiosperms. The expanding armamentarium of wearable activity monitors (WAMs) offers new opportunities to supplement physician-assessed performance status (PS) with real-life patient activity data. These data could guide clinical decision making or serve as a measure of treatment outcome. However, information on the association between physical activity (PA) and sedentary behavior (S monitored with wearables (i.e., WAM metrics) and PS in patients with cancer is